Safety and Efficacy of Intracameral Methotrexate and Targeted Radiotherapy for Subconjunctival Ocular Granulocytic Sarcoma: A Case Report

前房注射甲氨蝶呤联合靶向放射治疗治疗结膜下眼粒细胞肉瘤的安全性和有效性:病例报告

阅读:1

Abstract

A 28-year-old male patient with a history of acute myeloid leukemia, who was in complete remission for 18 months after allogeneic peripheral blood stem cell transplantation (PBSCT), developed a salmon-pink nodular lesion of the upper bulbar conjunctiva with conjunctival vascular engorgement of the right eye, accompanied by severe anterior uveitis and hypopyon. Ocular granulocytic sarcoma (OGS) was diagnosed based on immunohistochemistry analysis of the tissue sample and flow cytometry analysis of the aqueous humour, representing a local recurrence of acute myeloid leukemia. Systemic and central nervous system infiltration was excluded. Targeted radiotherapy of the right eye (24 Gy/12 cycles) and a series of 12 intracameral injections of methotrexate (400 μg/0.1 ml) were implemented with no impact on the endothelial cell count or corneal morphology. Complete macroscopic and cytometric remission of the lesion was achieved without leaving any permanent visual defects.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。